SK bioscience and VECOL Partner to Bolster Colombia’s Vaccine Production with $260 Million Initiative

SK bioscience and VECOL have entered into an agreement for vaccine technology transfer and manufacturing. The deal supports Colombia’s $260 million initiative to localize vaccine production.

The partnership between SK bioscience and VECOL will facilitate the transfer of vaccine manufacturing technology. This collaboration is a direct response to Colombia’s investment in strengthening its domestic vaccine production capabilities. The $260 million initiative aims to reduce reliance on foreign vaccine suppliers and enhance public health security within the country.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: May 27, 2026

Author

GOAI